1. Home
  2. TYL vs NBIX Comparison

TYL vs NBIX Comparison

Compare TYL & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyler Technologies Inc.

TYL

Tyler Technologies Inc.

HOLD

Current Price

$321.49

Market Cap

13.5B

Sector

Technology

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$130.00

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYL
NBIX
Founded
1966
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5B
13.2B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
TYL
NBIX
Price
$321.49
$130.00
Analyst Decision
Buy
Strong Buy
Analyst Count
11
22
Target Price
$474.36
$180.82
AVG Volume (30 Days)
423.2K
901.1K
Earning Date
04-22-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
19.01
41.95
EPS
7.20
4.67
Revenue
$493,101,000.00
$161,626,000.00
Revenue This Year
$9.59
$22.85
Revenue Next Year
$9.70
$10.36
P/E Ratio
$44.59
$27.09
Revenue Growth
18.35
977.51
52 Week Low
$283.72
$97.30
52 Week High
$621.34
$160.18

Technical Indicators

Market Signals
Indicator
TYL
NBIX
Relative Strength Index (RSI) 37.19 49.52
Support Level $283.72 $124.29
Resistance Level $365.00 $136.23
Average True Range (ATR) 11.09 4.29
MACD -1.38 -0.10
Stochastic Oscillator 20.09 55.93

Price Performance

Historical Comparison
TYL
NBIX

About TYL Tyler Technologies Inc.

Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: